Structure

Physi-Chem Properties

Molecular Weight:  314.15
Volume:  330.853
LogP:  2.867
LogD:  3.011
LogS:  -3.175
# Rotatable Bonds:  4
TPSA:  69.92
# H-Bond Aceptor:  4
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.81
Synthetic Accessibility Score:  3.187
Fsp3:  0.368
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.679
MDCK Permeability:  1.417483053955948e-05
Pgp-inhibitor:  0.004
Pgp-substrate:  0.998
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.979
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.054
Plasma Protein Binding (PPB):  87.93822479248047%
Volume Distribution (VD):  1.006
Pgp-substrate:  9.577905654907227%

ADMET: Metabolism

CYP1A2-inhibitor:  0.575
CYP1A2-substrate:  0.2
CYP2C19-inhibitor:  0.895
CYP2C19-substrate:  0.324
CYP2C9-inhibitor:  0.822
CYP2C9-substrate:  0.96
CYP2D6-inhibitor:  0.666
CYP2D6-substrate:  0.883
CYP3A4-inhibitor:  0.515
CYP3A4-substrate:  0.373

ADMET: Excretion

Clearance (CL):  15.252
Half-life (T1/2):  0.849

ADMET: Toxicity

hERG Blockers:  0.335
Human Hepatotoxicity (H-HT):  0.39
Drug-inuced Liver Injury (DILI):  0.019
AMES Toxicity:  0.17
Rat Oral Acute Toxicity:  0.474
Maximum Recommended Daily Dose:  0.985
Skin Sensitization:  0.956
Carcinogencity:  0.764
Eye Corrosion:  0.341
Eye Irritation:  0.955
Respiratory Toxicity:  0.925

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC153795

Natural Product ID:  NPC153795
Common Name*:   (1S,3S,5S)-1,7-Bis(4-Hydroxyphenyl)-1,5-Epoxy-3-Hydroxyheptane
IUPAC Name:   (2S,4S,6S)-2-(4-hydroxyphenyl)-6-[2-(4-hydroxyphenyl)ethyl]oxan-4-ol
Synonyms:  
Standard InCHIKey:  MRIKNBIACKXKEJ-FHWLQOOXSA-N
Standard InCHI:  InChI=1S/C19H22O4/c20-15-6-1-13(2-7-15)3-10-18-11-17(22)12-19(23-18)14-4-8-16(21)9-5-14/h1-2,4-9,17-22H,3,10-12H2/t17-,18-,19-/m0/s1
SMILES:  Oc1ccc(cc1)CC[C@H]1C[C@H](O)C[C@H](O1)c1ccc(cc1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2398583
PubChem CID:   71546305
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002650] Diarylheptanoids
        • [CHEMONTID:0002651] Linear diarylheptanoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14409 Dioscorea nipponica Species Dioscoreaceae Eukaryota rhizomes n.a. n.a. PMID[23707257]
NPO14409 Dioscorea nipponica Species Dioscoreaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO14409 Dioscorea nipponica Species Dioscoreaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO14409 Dioscorea nipponica Species Dioscoreaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO14409 Dioscorea nipponica Species Dioscoreaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO14409 Dioscorea nipponica Species Dioscoreaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT34 Cell Line BV-2 Mus musculus Activity = 95.6 % PMID[529626]
NPT34 Cell Line BV-2 Mus musculus IC50 = 38110.0 nM PMID[529626]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC153795 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC42911
1.0 High Similarity NPC290353
0.963 High Similarity NPC473556
0.963 High Similarity NPC301651
0.9524 High Similarity NPC306045
0.9524 High Similarity NPC265211
0.9238 High Similarity NPC135464
0.9238 High Similarity NPC92623
0.9189 High Similarity NPC476266
0.9143 High Similarity NPC154899
0.9143 High Similarity NPC233396
0.9043 High Similarity NPC174977
0.9038 High Similarity NPC91461
0.9038 High Similarity NPC7686
0.9038 High Similarity NPC40258
0.9 High Similarity NPC176730
0.9 High Similarity NPC123175
0.8942 High Similarity NPC213730
0.8879 High Similarity NPC255026
0.8846 High Similarity NPC216468
0.8846 High Similarity NPC78119
0.8846 High Similarity NPC132078
0.8846 High Similarity NPC51333
0.8807 High Similarity NPC474272
0.8803 High Similarity NPC38761
0.8803 High Similarity NPC76465
0.8739 High Similarity NPC276212
0.8727 High Similarity NPC475018
0.8727 High Similarity NPC63345
0.8718 High Similarity NPC36016
0.8718 High Similarity NPC100099
0.8707 High Similarity NPC201402
0.8707 High Similarity NPC160854
0.8707 High Similarity NPC469704
0.8707 High Similarity NPC469703
0.8655 High Similarity NPC17809
0.8655 High Similarity NPC188022
0.8655 High Similarity NPC102540
0.8655 High Similarity NPC285040
0.8655 High Similarity NPC103420
0.8644 High Similarity NPC473451
0.8632 High Similarity NPC469686
0.8632 High Similarity NPC54972
0.8621 High Similarity NPC8283
0.8621 High Similarity NPC258979
0.8621 High Similarity NPC93398
0.8596 High Similarity NPC175771
0.8595 High Similarity NPC245826
0.8595 High Similarity NPC274717
0.8595 High Similarity NPC252307
0.8595 High Similarity NPC148366
0.8595 High Similarity NPC311293
0.8595 High Similarity NPC474178
0.8571 High Similarity NPC134195
0.8571 High Similarity NPC86502
0.8571 High Similarity NPC197351
0.8571 High Similarity NPC246648
0.8571 High Similarity NPC106914
0.8559 High Similarity NPC471067
0.8547 High Similarity NPC470414
0.8532 High Similarity NPC113457
0.85 High Similarity NPC207179
0.85 High Similarity NPC278552
0.85 High Similarity NPC167571
0.8487 Intermediate Similarity NPC178449
0.8487 Intermediate Similarity NPC470907
0.8487 Intermediate Similarity NPC232454
0.8462 Intermediate Similarity NPC151715
0.8443 Intermediate Similarity NPC222572
0.8443 Intermediate Similarity NPC87224
0.8443 Intermediate Similarity NPC72529
0.8435 Intermediate Similarity NPC229147
0.8435 Intermediate Similarity NPC85292
0.8435 Intermediate Similarity NPC54507
0.8435 Intermediate Similarity NPC148055
0.843 Intermediate Similarity NPC26879
0.843 Intermediate Similarity NPC50315
0.843 Intermediate Similarity NPC283049
0.843 Intermediate Similarity NPC230479
0.8421 Intermediate Similarity NPC473137
0.8421 Intermediate Similarity NPC313193
0.8421 Intermediate Similarity NPC157338
0.8417 Intermediate Similarity NPC257682
0.8417 Intermediate Similarity NPC146355
0.8417 Intermediate Similarity NPC131747
0.8411 Intermediate Similarity NPC294741
0.8393 Intermediate Similarity NPC183700
0.8387 Intermediate Similarity NPC103799
0.8381 Intermediate Similarity NPC26244
0.8381 Intermediate Similarity NPC313650
0.8376 Intermediate Similarity NPC172253
0.8376 Intermediate Similarity NPC295259
0.8376 Intermediate Similarity NPC59561
0.8374 Intermediate Similarity NPC86030
0.8374 Intermediate Similarity NPC5851
0.8362 Intermediate Similarity NPC474933
0.8361 Intermediate Similarity NPC149796
0.8361 Intermediate Similarity NPC288416
0.8348 Intermediate Similarity NPC185541
0.8348 Intermediate Similarity NPC464
0.8347 Intermediate Similarity NPC81641
0.8333 Intermediate Similarity NPC474160
0.8333 Intermediate Similarity NPC471693
0.832 Intermediate Similarity NPC201587
0.832 Intermediate Similarity NPC253105
0.832 Intermediate Similarity NPC254275
0.8319 Intermediate Similarity NPC187583
0.8319 Intermediate Similarity NPC193364
0.8319 Intermediate Similarity NPC179002
0.8319 Intermediate Similarity NPC257430
0.8302 Intermediate Similarity NPC473388
0.8293 Intermediate Similarity NPC39064
0.8293 Intermediate Similarity NPC53986
0.8293 Intermediate Similarity NPC38664
0.8293 Intermediate Similarity NPC47283
0.8293 Intermediate Similarity NPC471064
0.8291 Intermediate Similarity NPC74821
0.8291 Intermediate Similarity NPC131118
0.8288 Intermediate Similarity NPC251306
0.8279 Intermediate Similarity NPC471215
0.8279 Intermediate Similarity NPC262573
0.8276 Intermediate Similarity NPC141090
0.8273 Intermediate Similarity NPC474839
0.8273 Intermediate Similarity NPC8302
0.8269 Intermediate Similarity NPC45040
0.8264 Intermediate Similarity NPC114901
0.8264 Intermediate Similarity NPC293701
0.8264 Intermediate Similarity NPC48990
0.8261 Intermediate Similarity NPC120280
0.8261 Intermediate Similarity NPC12656
0.8257 Intermediate Similarity NPC305205
0.825 Intermediate Similarity NPC150026
0.825 Intermediate Similarity NPC476142
0.824 Intermediate Similarity NPC162801
0.824 Intermediate Similarity NPC476166
0.824 Intermediate Similarity NPC196765
0.824 Intermediate Similarity NPC300875
0.824 Intermediate Similarity NPC280653
0.824 Intermediate Similarity NPC164574
0.824 Intermediate Similarity NPC228369
0.824 Intermediate Similarity NPC206224
0.824 Intermediate Similarity NPC268917
0.824 Intermediate Similarity NPC150011
0.824 Intermediate Similarity NPC129106
0.824 Intermediate Similarity NPC118114
0.824 Intermediate Similarity NPC207892
0.824 Intermediate Similarity NPC12875
0.824 Intermediate Similarity NPC129784
0.824 Intermediate Similarity NPC17343
0.824 Intermediate Similarity NPC236014
0.823 Intermediate Similarity NPC174096
0.823 Intermediate Similarity NPC226401
0.823 Intermediate Similarity NPC147634
0.823 Intermediate Similarity NPC120982
0.823 Intermediate Similarity NPC79793
0.823 Intermediate Similarity NPC44732
0.8226 Intermediate Similarity NPC93962
0.822 Intermediate Similarity NPC121866
0.8214 Intermediate Similarity NPC201959
0.8214 Intermediate Similarity NPC262365
0.8214 Intermediate Similarity NPC206341
0.8214 Intermediate Similarity NPC75440
0.8211 Intermediate Similarity NPC231607
0.8211 Intermediate Similarity NPC183181
0.8211 Intermediate Similarity NPC292056
0.8211 Intermediate Similarity NPC319625
0.8211 Intermediate Similarity NPC118787
0.8211 Intermediate Similarity NPC163332
0.8211 Intermediate Similarity NPC108659
0.8211 Intermediate Similarity NPC111247
0.8211 Intermediate Similarity NPC147821
0.8211 Intermediate Similarity NPC469687
0.8211 Intermediate Similarity NPC118533
0.8211 Intermediate Similarity NPC41706
0.8211 Intermediate Similarity NPC264900
0.8211 Intermediate Similarity NPC79715
0.8211 Intermediate Similarity NPC165045
0.8205 Intermediate Similarity NPC219070
0.8205 Intermediate Similarity NPC127894
0.8205 Intermediate Similarity NPC15860
0.8205 Intermediate Similarity NPC470759
0.8205 Intermediate Similarity NPC122117
0.8197 Intermediate Similarity NPC148627
0.8197 Intermediate Similarity NPC194519
0.819 Intermediate Similarity NPC232165
0.819 Intermediate Similarity NPC53906
0.819 Intermediate Similarity NPC138117
0.819 Intermediate Similarity NPC325292
0.8189 Intermediate Similarity NPC478085
0.8182 Intermediate Similarity NPC212176
0.8182 Intermediate Similarity NPC119860
0.8182 Intermediate Similarity NPC323810
0.8175 Intermediate Similarity NPC13005
0.8173 Intermediate Similarity NPC300478
0.8173 Intermediate Similarity NPC300017
0.8167 Intermediate Similarity NPC312675
0.8167 Intermediate Similarity NPC184651
0.8167 Intermediate Similarity NPC476633
0.8167 Intermediate Similarity NPC97432
0.8167 Intermediate Similarity NPC54872

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC153795 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8381 Intermediate Similarity NPD2860 Approved
0.8381 Intermediate Similarity NPD2859 Approved
0.8319 Intermediate Similarity NPD1610 Phase 2
0.8293 Intermediate Similarity NPD4908 Phase 1
0.8291 Intermediate Similarity NPD1548 Phase 1
0.8286 Intermediate Similarity NPD2933 Approved
0.8286 Intermediate Similarity NPD2934 Approved
0.8211 Intermediate Similarity NPD2861 Phase 2
0.816 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8148 Intermediate Similarity NPD3020 Approved
0.808 Intermediate Similarity NPD3027 Phase 3
0.8031 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8031 Intermediate Similarity NPD1613 Approved
0.8 Intermediate Similarity NPD5238 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD2684 Approved
0.7876 Intermediate Similarity NPD968 Approved
0.7838 Intermediate Similarity NPD940 Approved
0.7838 Intermediate Similarity NPD846 Approved
0.7778 Intermediate Similarity NPD7843 Approved
0.7748 Intermediate Similarity NPD1242 Phase 1
0.7742 Intermediate Similarity NPD6582 Phase 2
0.7742 Intermediate Similarity NPD4659 Approved
0.7742 Intermediate Similarity NPD6583 Phase 3
0.7724 Intermediate Similarity NPD1091 Approved
0.7717 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.771 Intermediate Similarity NPD4536 Approved
0.771 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.771 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.771 Intermediate Similarity NPD4538 Approved
0.7705 Intermediate Similarity NPD5846 Approved
0.7705 Intermediate Similarity NPD6516 Phase 2
0.7672 Intermediate Similarity NPD3021 Approved
0.7672 Intermediate Similarity NPD3022 Approved
0.7672 Intermediate Similarity NPD5451 Approved
0.7669 Intermediate Similarity NPD7266 Discontinued
0.7652 Intermediate Similarity NPD5960 Phase 3
0.7652 Intermediate Similarity NPD5588 Approved
0.7638 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD5535 Approved
0.7619 Intermediate Similarity NPD4103 Phase 2
0.7619 Intermediate Similarity NPD4104 Clinical (unspecified phase)
0.7615 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.7583 Intermediate Similarity NPD7157 Approved
0.7561 Intermediate Similarity NPD5125 Phase 3
0.7561 Intermediate Similarity NPD5126 Approved
0.7559 Intermediate Similarity NPD6584 Phase 3
0.7556 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7541 Intermediate Similarity NPD7741 Discontinued
0.7541 Intermediate Similarity NPD3091 Approved
0.7538 Intermediate Similarity NPD6407 Approved
0.7538 Intermediate Similarity NPD6405 Approved
0.7537 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7537 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7537 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7521 Intermediate Similarity NPD9380 Clinical (unspecified phase)
0.7519 Intermediate Similarity NPD7033 Discontinued
0.7519 Intermediate Similarity NPD4625 Phase 3
0.75 Intermediate Similarity NPD290 Approved
0.7481 Intermediate Similarity NPD1549 Phase 2
0.748 Intermediate Similarity NPD3094 Phase 2
0.7464 Intermediate Similarity NPD7212 Phase 2
0.7464 Intermediate Similarity NPD7213 Phase 3
0.7462 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7462 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7462 Intermediate Similarity NPD3764 Approved
0.746 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.746 Intermediate Similarity NPD4749 Approved
0.744 Intermediate Similarity NPD3092 Approved
0.7438 Intermediate Similarity NPD6671 Approved
0.7434 Intermediate Similarity NPD3028 Approved
0.7429 Intermediate Similarity NPD111 Approved
0.7424 Intermediate Similarity NPD5124 Phase 1
0.7424 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7417 Intermediate Similarity NPD5283 Phase 1
0.7402 Intermediate Similarity NPD8651 Approved
0.7398 Intermediate Similarity NPD9545 Approved
0.7391 Intermediate Similarity NPD5058 Phase 3
0.7381 Intermediate Similarity NPD2561 Approved
0.7381 Intermediate Similarity NPD2562 Approved
0.7368 Intermediate Similarity NPD3052 Approved
0.7368 Intermediate Similarity NPD3054 Approved
0.736 Intermediate Similarity NPD3847 Discontinued
0.7333 Intermediate Similarity NPD821 Approved
0.7328 Intermediate Similarity NPD6798 Discontinued
0.7323 Intermediate Similarity NPD3685 Discontinued
0.7302 Intermediate Similarity NPD422 Phase 1
0.7293 Intermediate Similarity NPD4340 Discontinued
0.7286 Intermediate Similarity NPD7447 Phase 1
0.728 Intermediate Similarity NPD3095 Discontinued
0.7273 Intermediate Similarity NPD6233 Phase 2
0.7273 Intermediate Similarity NPD4380 Phase 2
0.7266 Intermediate Similarity NPD7258 Clinical (unspecified phase)
0.7259 Intermediate Similarity NPD1510 Phase 2
0.7258 Intermediate Similarity NPD1894 Discontinued
0.7258 Intermediate Similarity NPD6581 Approved
0.7258 Intermediate Similarity NPD6580 Approved
0.725 Intermediate Similarity NPD228 Approved
0.7246 Intermediate Similarity NPD4628 Phase 3
0.7244 Intermediate Similarity NPD2235 Phase 2
0.7244 Intermediate Similarity NPD2231 Phase 2
0.7236 Intermediate Similarity NPD3596 Phase 2
0.7232 Intermediate Similarity NPD844 Approved
0.7232 Intermediate Similarity NPD1809 Phase 2
0.7227 Intermediate Similarity NPD4750 Phase 3
0.7218 Intermediate Similarity NPD4060 Phase 1
0.7218 Intermediate Similarity NPD2238 Phase 2
0.7207 Intermediate Similarity NPD845 Approved
0.72 Intermediate Similarity NPD6830 Clinical (unspecified phase)
0.7194 Intermediate Similarity NPD6190 Approved
0.7177 Intermediate Similarity NPD856 Approved
0.7177 Intermediate Similarity NPD16 Approved
0.7174 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD5351 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD1535 Discovery
0.7165 Intermediate Similarity NPD5350 Clinical (unspecified phase)
0.7164 Intermediate Similarity NPD5735 Approved
0.7163 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7154 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD2668 Approved
0.7143 Intermediate Similarity NPD2667 Approved
0.7132 Intermediate Similarity NPD3225 Approved
0.7131 Intermediate Similarity NPD2229 Approved
0.7131 Intermediate Similarity NPD2228 Approved
0.7131 Intermediate Similarity NPD2234 Approved
0.7131 Intermediate Similarity NPD7159 Clinical (unspecified phase)
0.7122 Intermediate Similarity NPD4535 Phase 3
0.7121 Intermediate Similarity NPD6179 Discontinued
0.7119 Intermediate Similarity NPD3134 Approved
0.7109 Intermediate Similarity NPD1481 Phase 2
0.7107 Intermediate Similarity NPD6124 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD5736 Approved
0.709 Intermediate Similarity NPD4140 Approved
0.709 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.709 Intermediate Similarity NPD5837 Clinical (unspecified phase)
0.709 Intermediate Similarity NPD3620 Phase 2
0.709 Intermediate Similarity NPD1240 Approved
0.7077 Intermediate Similarity NPD2797 Approved
0.7077 Intermediate Similarity NPD4339 Clinical (unspecified phase)
0.7068 Intermediate Similarity NPD3056 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD1358 Approved
0.7059 Intermediate Similarity NPD2342 Discontinued
0.7059 Intermediate Similarity NPD7097 Phase 1
0.7054 Intermediate Similarity NPD2982 Phase 2
0.7054 Intermediate Similarity NPD2983 Phase 2
0.7054 Intermediate Similarity NPD5327 Phase 3
0.7054 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD1652 Phase 2
0.705 Intermediate Similarity NPD3060 Approved
0.7042 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.704 Intermediate Similarity NPD317 Approved
0.704 Intermediate Similarity NPD318 Approved
0.7037 Intermediate Similarity NPD6355 Discontinued
0.7034 Intermediate Similarity NPD5048 Discontinued
0.7023 Intermediate Similarity NPD3690 Phase 2
0.7023 Intermediate Similarity NPD3691 Phase 2
0.7018 Intermediate Similarity NPD288 Approved
0.7016 Intermediate Similarity NPD2557 Approved
0.7015 Intermediate Similarity NPD4062 Phase 3
0.7007 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD4108 Discontinued
0.7007 Intermediate Similarity NPD3846 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD3750 Approved
0.6992 Remote Similarity NPD3180 Approved
0.6992 Remote Similarity NPD7095 Approved
0.6992 Remote Similarity NPD3179 Approved
0.6986 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6985 Remote Similarity NPD2568 Approved
0.6985 Remote Similarity NPD1607 Approved
0.6983 Remote Similarity NPD289 Clinical (unspecified phase)
0.6983 Remote Similarity NPD2549 Approved
0.6983 Remote Similarity NPD2550 Approved
0.6983 Remote Similarity NPD2553 Approved
0.6983 Remote Similarity NPD2552 Approved
0.6983 Remote Similarity NPD2555 Approved
0.6983 Remote Similarity NPD2558 Approved
0.698 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6977 Remote Similarity NPD1608 Approved
0.6977 Remote Similarity NPD2981 Phase 2
0.6975 Remote Similarity NPD3526 Approved
0.6975 Remote Similarity NPD3524 Approved
0.6972 Remote Similarity NPD7041 Phase 2
0.6972 Remote Similarity NPD7040 Clinical (unspecified phase)
0.697 Remote Similarity NPD3018 Phase 2
0.6966 Remote Similarity NPD6057 Approved
0.6966 Remote Similarity NPD6056 Approved
0.6963 Remote Similarity NPD3059 Approved
0.6963 Remote Similarity NPD3062 Approved
0.6963 Remote Similarity NPD3061 Approved
0.6959 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6957 Remote Similarity NPD2796 Approved
0.6947 Remote Similarity NPD1131 Approved
0.6947 Remote Similarity NPD1133 Approved
0.6947 Remote Similarity NPD1129 Approved
0.6947 Remote Similarity NPD1135 Approved
0.6947 Remote Similarity NPD1134 Approved
0.694 Remote Similarity NPD3268 Approved
0.6939 Remote Similarity NPD1934 Approved
0.6935 Remote Similarity NPD1476 Clinical (unspecified phase)
0.6934 Remote Similarity NPD3553 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data